Published on in Vol 11, No 5 (2022): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35969, first published .
Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Cristian Garcia   1 , BSc ;   Nadia Rehman   1 , BDS ;   Daeria O Lawson   1 , HBSc ;   Pascal Djiadeu   1 , PhD ;   Lawrence Mbuagbaw   1, 2, 3, 4, 5 , MPH, MD, PhD

1 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

2 Department of Anesthesia, McMaster University, Hamilton, ON, Canada

3 Department of Pediatrics, McMaster University, Hamilton, ON, Canada

4 Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, ON, Canada

5 Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa

Corresponding Author:

  • Lawrence Mbuagbaw, MPH, MD, PhD
  • Department of Health Research Methods, Evidence, and Impact
  • McMaster University
  • 1280 Main Street West
  • Hamilton, ON, L8S 4K1
  • Canada
  • Phone: 1 905-522-1155 ext 35929
  • Email: mbuagblc@mcmaster.ca